Default: Current Drug Targets

ISSN: 1389-4501

Journal Home

Journal Guideline

Current Drug Targets Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 119. It has a price of 1800 €. It has an SJR impact factor of 0,691 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,691.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

1800 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Current Drug Targets

0,691

SJR Impact factor

119

H Index

97

Total Docs (Last Year)

390

Total Docs (3 years)

10001

Total Refs

1214

Total Cites (3 years)

368

Citable Docs (3 years)

2.96

Cites/Doc (2 years)

103.1

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Retinal Angiomatous Proliferation

View more

Mitochondrial Drug Targets in Apicomplexan Parasites

View more

Molecular Targeting of Drug Delivery Systems to Cancer

View more

Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy

View more

Molecular Targets for Design of Novel Inhibitors to Circumvent Aminoglycoside Resistance

View more

Chemokines and Their Receptors in Central Nervous System Disease

View more

Chemokines as Potential Therapeutic Targets in Atherosclerosis

View more

Chemokines in Gastrointestinal Disorders

View more

Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics

View more

Chemokines in Rheumatic Diseases

View more

Computational Approaches for Elucidating Protein-Protein Interactions in Cation Channel Signaling

View more

Targeting Purine and Pyrimidine Metabolism in Human Apicomplexan Parasites

View more
SHOW MORE ARTICLES

Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets

View more

Isoprenoid Biosynthesis of the Apicoplast as Drug Target

View more

Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells

View more

Prevalence and clinical significance of visible oral lesions in patients with Fanconi Anemia at risk for head and neck cancer

View more

Nanoparticle-Based Diagnosis and Therapy

View more

NMDA Receptors and Learning and Memory Processes

View more

Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling

View more

Modifying Radiation Damage

View more

Molecular Modeling as a Tool for Drug Discovery

View more

Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction

View more

Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review

View more

ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis

View more

FAQS